Navigation Links
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Date:10/4/2007

nces Capital. This funding, in addition to the recently announced $40 million in Series B financing, will enable the Company to advance clinical trials of GT4P for potential use in urea cycle disorder (UCD) and hepatic encephalopathy (HE) and AMMONUL for potential use in acute HE. Further, the funds will be used to invest in the U.S. sales and marketing efforts of the only two FDA-approved compounds for the treatment of UCD, AMMONUL and BUPHENYL.

About Hyperion Therapeutics

Hyperion Therapeutics is a specialty therapeutics company focused on becoming a global leader in gastrointestinal (GI) and hepatology therapeutic programs and products that address underserved patient populations or unmet medical needs. The company has assembled a seasoned executive team with extensive industry experience developing and commercializing specialty pharmaceutical products. Hyperion is headquartered in South San Francisco, CA. For additional information, visit: http://www.hyperiontx.com.

About AMMONUL

AMMONUL is indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. The most common adverse reactions are vomiting (9%), hypokalemia (7%), hyperglycemia (7%), convulsions (6%), and mental impairments (6%). Do not administer to patients with known hypersensitivity to sodium phenylacetate or sodium benzoate. Acute symptomatic hyperammonemia should be treated as life-threatening. Uncontrolled hyperammonemia can result in brain damage or death. Dialysis may be required, preferably hemodialysis, to remove a large burden of ammonia. Administration must be through a central line; use of a peripheral line may cause burns. Do not administer undiluted product. Because of prolonged plasma levels achieved by phenylacetate in pharmacokinetic studies, repeat loading doses should not be administered. Use caution when ad
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...s is accelerating improvements for converting plan...fuel for the nation,s transportation needs, report...nergy Joint Genome Institute (DOE JGI), in the Aug...ics of cellulosic biofuels," Rubin lays out a path...l contribute to a substantially different biofuels...
...a, Aug. 13 /Xinhua-PRNewswire-FirstCall/ --,China ... (,CBP, or the,Company,), one of the leading plasm...epublic of China (,PRC,), today announced that, ef... established a Governance and,Nominating Committee...ach,of the Company,s current independent directors...
...bol: MS, - Milestone triggers $10 million payment...PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX:,...ple sclerosis (MS), today,announced that the indep...,MAESTRO-01 trial has conducted the scheduled inte...ended that the trial continue to completion.,MAEST...
Other Biology Technology:DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 2DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 3DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 4China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee 2China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee 3China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee 4BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 2BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 3BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 4
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
Breaking Biology News(10 mins):Stem cells battle for space 2Lower income women report more insurance-based discrimination during pregnancy, delivery 2Scientists think 'killer petunias' should join the ranks of carnivorous plants 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 1First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 3First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 4Daily sex helps to reduce sperm DNA damage and improve fertility 50401 1Daily sex helps to reduce sperm DNA damage and improve fertility 50401 2Daily sex helps to reduce sperm DNA damage and improve fertility 50401 3Patients with moderate to severe periodontitis need evaluation for heart disease risk 50398 1Patients with moderate to severe periodontitis need evaluation for heart disease risk 50398 2
...at about genetically modified crops, according to ...earch Council (ESRC). , A group at the Open Univ...first systematic look at what large-scale, commodi...rowing - think about genetically-modified crops. W...ustry regard GM, but this is the first proper look...
...be carried out at The University of Nottingham cou...ggling with low back pain are helped to stay in wo...nce from work in the UK. In 2004-5 approximately 3...sculoskeletal disorders affecting their backs, whi...r current or past work. , Now medical research ch...
...tanding of how memory works is emerging from a new...ouse to consequent changes in the inner workings o...he National Institutes of Health,s National Instit...to pinpoint the specific cellular components that ...d mice. , "Remarkably, this research demonstrates...
Other Biology News:What farmers think about GM crops 2Helping back pain sufferers to stay in work 2Genetic tags reveal secrets of memories' staying power in mice 2Genetic tags reveal secrets of memories' staying power in mice 3
Acridine orange; 10 mg/mL solution in water from AnaSpec
Rabbit Anti-Human Q96IR3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
12-Tube Magnetic Separation Rack from New England Biolabs
Bromphenol Blue, ACS Reagent from Research Organics, Inc.
Biology Products: